Clinical trials
Pneumocystis clinical trials
Below are recruiting pneumocystis clinical trials, each written for real people, not researchers. We’re tracking 8 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04851015RecruitingPhase 3
Low-dose TMP-SMX for Pneumocystis pneumonia (PCP)
This Phase 3 study tests whether low-dose trimethoprim-sulfamethoxazole (also called TMP-SMX) can treat Pneumocystis pneumonia (PCP) in people with weakened immune systems. It may help improve treatment while reducing side effects compared with standard dosing.
Montreal, QuebecAges 18–100 - NCT05835479RecruitingPhase 2
Rezafungin to treat Pneumocystis pneumonia in adults with HIV
This Phase 2 trial tests rezafungin, an antifungal medicine, to treat Pneumocystis pneumonia (PCP) in adults living with HIV. It may help people recover faster or more effectively from this serious lung infection.
Cape TownAges 18 years+ - NCT06499233RecruitingPhase 4
Study on preventing pneumocystis pneumonia in autoimmune disease
This trial tests whether a preventive treatment can stop pneumocystis pneumonia (a lung infection) in people with autoimmune inflammatory rheumatic diseases who are taking steroids or other immune-suppressing medicines. It aims to find the safest and most effective way to protect you from this serious infection.
Wuhan, HubeiAges 18 years+ - NCT06691321Recruiting
Caspofungin for Pneumocystis Pneumonia in HIV patients
This trial tests caspofungin, a medicine, for treating Pneumocystis pneumonia (PCP) in people living with HIV. It aims to see if it works better than standard treatments.
Mexico City, TlalpanAges 18–60 - NCT06890078Recruiting
Better diagnosis of pneumocystis in patients with weak immune systems
This trial tests a new way to diagnose pneumocystis, a lung infection that can affect people with weakened immune systems. It may help find the infection faster and more accurately using samples taken from your lungs.
ParisAges 18 years+ - NCT07681583Recruiting
Fungal pneumonia risk score study
This study is developing a tool to better predict fungal pneumonia in people who come to the emergency department or hospital with pneumonia. By analyzing samples from your lungs and other data, researchers hope to improve diagnosis and treatment decisions.
FlorenceAges 18–90 - NCT07269314Recruiting
Comparing PCR tests to standard methods for infections
This trial uses stored samples to see if a newer test (PCR) is as good as standard tests at detecting three infections: Pneumocystis (a lung infection), malaria, and leishmaniasis. It does not involve new treatments.
Pavia, LombardyAges Any age - NCT03856229Enrolling by invitation
Short steroid treatment for lung infection from PCP in HIV
This study tests whether short-term steroid treatment helps adults with a specific lung infection (PCP) that happens with HIV/AIDS. It compares outcomes in people who start steroids soon after admission while also taking standard PCP antibiotics.
México, State of MexicoAges 18–80
Hear when a new Pneumocystis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pneumocystis?
- Yes. Clin2 currently lists 8 recruiting pneumocystis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pneumocystis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pneumocystis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.